December 16, 2020 by Chain Drug Review
COVID-19, SingleCare
Business, Leading Headlines, Pharmacy
BOSTON — SingleCare (prescription savings service) just released a new report that explores major shifts in 2020 prescription drug trends due to COVID. This year was a watershed moment for healthcare’s national impact to access to medications. From the start of the outbreak in the U.S. in March 2020, millions across the country experienced drug
December 14, 2020 by Chain Drug Review
COVID-19, Hy-Vee
Leading Headlines, Pharmacy
WEST DES MOINES, Iowa — Hy-Vee pharmacists and technicians who take part in the company’s rapid antigen COVID-19 testing will be offered an additional bonus for participating in the public health program. Full-time pharmacists who administer the tests will receive a $500 bonus and part-time pharmacists and technicians who administer the test will receive a $250 bonus.
December 10, 2020 by Chain Drug Review
COVID-19, IRI
Business, Leading Headlines
CHICAGO — COVID-19 vaccines have begun in the United Kingdom and Canada, with the US markets to follow very soon. Strong adoption of vaccinations will increase consumer confidence and speed up social mobility, ultimately driving economic growth. IRI’s latest report, “Anticipated Vaccine Adoption and Impact on CPG Industry,”explores the opportunities that retailers and manufacturers have to
December 10, 2020 by Chain Drug Review
COVID-19, CVS Health, Eileen Howard Boone, Project Health flu initiative
Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health is supporting a nearly $3 million commitment to increasing access to flu vaccines for underserved communities throughout the country. Through its Project Health initiative, CVS Health is contributing $2 million to the National Association of Free and Charitable Clinics (NAFC) to help distribute flu vaccines to those who may otherwise not have access.
December 9, 2020 by Chain Drug Review
COVID-19, Dr. Kevin Ban, Walgreens, Walgreens Flu Index
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. – During National Influenza Vaccination Week, Walgreens has launched the Walgreens Flu Index for the 2020-2021 season to help communities track flu activity in their area and serve as a reminder to get vaccinated against the flu. With COVID-19 cases continuing to surge across the country, health experts are encouraging flu shots to
December 8, 2020 by Chain Drug Review
COVID-19, National Pharmacy Technician Association (NPTA)
Leading Headlines, Pharmacy
HOUSTON — As COVID-19 continues to spread across the United States and vaccine distribution to begin possibly this week, the National Pharmacy Technician Association (NPTA) is announcing the launch of a nationally-recognized pharmacy technician administered immunization training program. Developed under the guidance of the U.S. Department of Health and Human Services (HHS), NPTA’s Immunization Administration
December 8, 2020 by Chain Drug Review
COVID-19, FDA
Leading Headlines, Pharmacy
WASHINGTON — The coronavirus vaccine from Pfizer and BioNTech is said to offer strong protection against COVID-19 within about 10 days of the first dose, according to information published on Tuesday by the Food and Drug Administration ahead of a meeting of its vaccine advisory group. The finding is one of several significant new results
December 8, 2020 by Chain Drug Review
COVID-19, Xlear
Supplier News
WASHINGTON — Xlear is filing a Pre-Emergency Use Authorization (Pre-EUA) Request with the U.S. Food and Drug Administration (FDA). The Pre-EUA is a first step in seeking authorization of Xlear Nasal Spray as a new hygiene tool to help in combat the SARS-CoV-2 virus, the virus that causes COVID-19. Xlear’s Pre-EUA Request is based on
December 4, 2020 by Chain Drug Review
Bob Katter, COVID-19, COVID-19 Medical Supply Guide, First Databank (FDB
Leading Headlines, Pharmacy
SOUTH SAN FRANCISCO – First Databank (FDB) announced today it is updating its COVID-19 Medical Supply Guide to feature new products that have become available, including SARS-CoV-2 test kits, personal protective equipment (PPE) and disinfectants. More than 1,300 new products across these categories have been added to the FDB COVID-19 Medical Supply Guide, which is available
December 4, 2020 by Chain Drug Review
bamlanivimab (LY-CoV555) in high-risk, COVID-19, COVID-19 infected individuals, Eli Lilly and Co., UnitedHealth Group
Leading Headlines, Pharmacy
INDIANAPOLIS — Eli Lilly and Co. and the UnitedHealth Group have announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals. Bamlanivimab recently received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration for the treatment of mild to moderate COVID-19 patients who are at high risk
December 3, 2020 by Chain Drug Review
Cardinal Health, COVID-19, These findings were released today in the eighth edition of Oncology Insights
Leading Headlines, Pharmacy
DUBLIN, Ohio — In response to the COVID-19 pandemic, U.S. oncologists have adjusted patient care by embracing telemedicine and switching more patients to oral therapies to limit office visits—but personally, more oncologists may be experiencing burnout due to the loss of face-to-face interactions with patients, according to new research from Cardinal Health Specialty Solutions.
December 2, 2020 by Chain Drug Review
COVID-19, NACDS, Pennsylvania Governor Tom Wolf (D), Steven Anderson
Leading Headlines, Pharmacy
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today hailed a new law that will increase Pennsylvanians’ access to health care as the COVID-19 pandemic converges with the 2020-2021 flu season. Pennsylvania Governor Tom Wolf (D) on November 30 signed into law legislation (Act 140) sponsored by State Rep. Tony DeLuca (D) that
December 1, 2020 by Chain Drug Review
Black Friday, COVID-19, NRF
Business, Leading Headlines, Retail News
WASHINGTON – Fewer people than usual shopped in stores over the Thanksgiving holiday weekend this year, according to the annual survey released Tuesday by the National Retail Federation and Prosper Insights & Analytics. The number of in-store shoppers on Thanksgiving Day dropped by 55% from last year and those on Black Friday dropped by 37%.
November 30, 2020 by Chain Drug Review
COVID-19, Xlear Nasal Spray
Supplier News
MIAMI — New in vitro studies, led by renowned authority on respiratory diseases, conclude Xlear nasal spray is “an effective…and replicable means to deactivate SARS-CoV-2…to an undetectable amount of infectious virus.” This conclusion is “validated by two independent sets of experiments, performed by different labs, on different viral strains…” The Virucidal studies were independently funded.